97 related articles for article (PubMed ID: 36159076)
1. Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature.
Yang X; Deng X; Wu M; Chen SW; Jiang M; Long L; Chen BT
Insights Imaging; 2024 Feb; 15(1):40. PubMed ID: 38353902
[TBL] [Abstract][Full Text] [Related]
2. Clinical analysis of malignant lymphoma secondary to transplantation: the notorious lymphoproliferative disease.
Yan Z; Wang H; Liu Y; Yin Y; Zhao M
Am J Transl Res; 2023; 15(11):6632-6643. PubMed ID: 38074803
[TBL] [Abstract][Full Text] [Related]
3. Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P; Bomken S; Ling R; Lazareva A; Gupte G; Amrolia P; Andrés M; Diez-Sebastián J; Taj MM
Pediatr Blood Cancer; 2024 May; ():e31053. PubMed ID: 38757407
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Refractory Post-Transplant Lymphoproliferative Disorder With Chimeric Antigen Receptor T-Cell Therapy in a Heart Transplant Recipient.
Hickmann K; Sweeney R; Peterson C; Faringer K; Riley M; Bunker M; Hadi A; Khan C; Samhouri Y
J Hematol; 2024 Apr; 13(1-2):34-38. PubMed ID: 38644987
[TBL] [Abstract][Full Text] [Related]
5. Post-transplant lymphoproliferative disorder: risk factors and management.
Malyszko J
Nephrol Dial Transplant; 2019 Oct; ():. PubMed ID: 31598720
[No Abstract] [Full Text] [Related]
6. How we treat diarrhea in pediatric transplant patients: a brief review.
Minniear TD; Vora S
Front Pediatr; 2023; 11():1287445. PubMed ID: 38161440
[TBL] [Abstract][Full Text] [Related]
7. Post-transplantation Lymphoproliferative Disorder (PTLD): In the Liver Transplant Recipient.
Janeela AM; Fouzia NA; Zachariah UG
J Clin Exp Hepatol; 2024; 14(2):101286. PubMed ID: 38076446
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal manifestations, risk factors, and management in patients with post-transplant lymphoproliferative disorder: A systematic review.
Reiche W; Tauseef A; Sabri A; Mirza M; Cantu D; Silberstein P; Chandan S
World J Transplant; 2022 Aug; 12(8):268-280. PubMed ID: 36159076
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
10. Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.
Styczynski J; Gil L; Tridello G; Ljungman P; Donnelly JP; van der Velden W; Omar H; Martino R; Halkes C; Faraci M; Theunissen K; Kalwak K; Hubacek P; Sica S; Nozzoli C; Fagioli F; Matthes S; Diaz MA; Migliavacca M; Balduzzi A; Tomaszewska A; Camara Rde L; van Biezen A; Hoek J; Iacobelli S; Einsele H; Cesaro S;
Clin Infect Dis; 2013 Sep; 57(6):794-802. PubMed ID: 23771985
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report.
Dutta R; Miao SY; Phan P; Fernandez-Pol S; Shiraz P; Ho D; Mannis GN; Zhang TY
J Med Case Rep; 2021 Mar; 15(1):170. PubMed ID: 33773605
[TBL] [Abstract][Full Text] [Related]
12. Risk factors evaluation of post-transplant lymphoproliferative disorders after allogeneic haematopoietic stem cell transplantation with comparison between paediatric and adult.
Chen DB; Liu XY; Kong FZ; Jiang Q; Shen DH
J Clin Pathol; 2021 Nov; 74(11):697-703. PubMed ID: 34011618
[TBL] [Abstract][Full Text] [Related]
13. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
